Our pipeline of new medicines is the largest in the pharmaceutical industry, focusing on a broad range of unmet medical needs spanning 11 Therapeutic Areas. Pfizer invests more than £4 billion annually in the research and development of new products across more therapeutic areas than any other company in our industry. Relying on the strength of our pipeline and scientific talent, Pfizer has generated a steady stream of breakthroughs over the years, and our researchers continue to work around the clock and around the globe to ensure the best medicines for our patients in the years to come.
Pfizer regularly publishes a report detailing the product candidates in its pipeline, which is available on our US web site:
The Pfizer pipeline
Please note that this link directs you to our US web site, and is provided for convenience. Pfizer Ltd can accept no responsibility for the content of external web sites.